Cargando…
Investigation of a new tumor-associated glycosylated antigen as target for dendritic cell vaccination in pancreatic cancer
Glycoproteins, as valuable targets for dendritic cell (DC)-vaccination in cancers, remain an open question. Glycosylated structures, which are aberrantly modified during cancerisation, impact positively or negatively on glycoprotein immunogenicity. Here is presented an oncofetal glycovariant of bile...
Autores principales: | Béraud, Evelyne, Collignon, Aurélie, Franceschi, Cécile, Olive, Daniel, Lombardo, Dominique, Mas, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376954/ https://www.ncbi.nlm.nih.gov/pubmed/22720212 http://dx.doi.org/10.4161/onci.1.1.18459 |
Ejemplares similares
-
Pancreatic adenocarcinoma, chronic pancreatitis, and MODY-8 diabetes: is bile salt-dependent lipase (or carboxyl ester lipase) at the crossroads of pancreatic pathologies?
por: Lombardo, Dominique, et al.
Publicado: (2017) -
A pancreatic tumor-specific biomarker characterized in humans and mice as an immunogenic onco-glycoprotein is efficient in dendritic cell vaccination
por: Collignon, Aurélie, et al.
Publicado: (2015) -
Antibody glycosylation in COVID-19
por: Pongracz, Tamas, et al.
Publicado: (2022) -
Exosomal Lipids Impact Notch Signaling and Induce Death of Human Pancreatic Tumoral SOJ-6 Cells
por: Beloribi, Sadia, et al.
Publicado: (2012) -
Protein glycosylation in infectious disease pathobiology and treatment
por: Vigerust, David J.
Publicado: (2011)